Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients
暂无分享,去创建一个
T. Roskams | G. Meyfroidt | F. Nevens | C. Verslype | W. Laleman | V. Vandecaveye | A. Wilmer | G. Hermans | D. Monbaliu | H. van Malenstein | N. Gilbo | J. Pirenne | J. Wauters | G. De Vlieger | J. Gunst | C. Vandenbriele | M. Verhaegen | P. Meersseman | I. Jochmans | P. Rogiers | J. Verbeek | S. van der Merwe | Y. Debaveye | T. Balthazar | M. S. Barriga | Joris Blondeel | Joost Alexander Nicholas Ina Jacques Mauricio Sainz Yves Wauters Wilmer Gilbo Jochmans Pirenne Barri
[1] J. Schulte am Esch,et al. Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19 , 2021, Clinical Gastroenterology and Hepatology.
[2] G. Van den Berghe,et al. Intensive care unit acquired muscle weakness in COVID-19 patients , 2020, Intensive Care Medicine.
[3] H. Krumholz,et al. Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.
[4] Mariana Verdelho Machado,et al. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity , 2019, GE - Portuguese Journal of Gastroenterology.
[5] E. Björnsson,et al. Secondary sclerosing cholangitis in critically ill patients: current perspectives , 2017, Clinical and experimental gastroenterology.